CHINYANG CHEMICAL CORPORATION: debt-to-equity, ROE and more
KOSPI, Legal name CHINYANG CHEMICAL CORPORATION
Latest figures are the FY2025 separate summary statements.
Latest fiscal year ratios (computed here)
- Debt/equity
- 107.1%
- Equity ratio
- 48.3%
- ROE
- 2.3%
- Op. margin
- -4.0%
- Rev. growth
- -24.3%
- Interest coverage
- n/a
Condition flags
- Latest operating profit is not above zero, or not reported.
- Operating loss for 5 straight years.
- Total equity is above paid-in capital. Not capital-impaired.
Interest coverage and dividends (OpenDART)
Interest expense and dividends come from DART's OpenDART annual-report filings, not the FSC summary statements used above. The source differs from the other tables on this page.
Interest coverage = operating profit ÷ interest expenseNo interest expense value yet for this company. Most companies fold interest expense into a single finance-costs line on their income statement, so it cannot be pulled out separately. Interest coverage is not computed here.
Dividends, last 3 fiscal years
No dividend data yet for this company.
Source values from the OpenDART (금융감독원 전자공시) annual report. Report fiscal year 2025.
Ratios by year (computed here)
Debt-to-equity = total liabilities ÷ total equity × 100Equity ratio = total equity ÷ total assets × 100ROE = net income ÷ year-end total equity × 100Operating margin = operating profit ÷ revenue × 100Revenue growth = (this year − last year) ÷ last year × 100
Computed from the source figures above with these formulas. Where the source's own debt-to-equity differs from ours, both are shown for that year.
| Fiscal year | Debt/equity | Equity ratio | ROE | Op. margin | Rev. growth |
|---|---|---|---|---|---|
| FY2021 separate | 32.5% | 75.4% | -8.7% | -11.1% | n/a |
| FY2022 separate | 28.3% | 77.9% | -3.2% | -3.6% | -16.4% |
| FY2023 separate | 53.2% | 65.3% | -6.7% | -7.6% | -2.8% |
| FY2024 separate | 111.6% | 47.3% | -11.6% | -16.9% | -13.3% |
| FY2025 separate | 107.1% | 48.3% | 2.3% | -4.0% | -24.3% |
Source figures (FSC summary statements)
Amounts are the source values, shortened. A cell reported as zero may be blank in the source, so it is not used in any ratio.
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | ₩34.8B | ₩29.1B | ₩28.3B | ₩24.5B | ₩18.6B |
| Operating profit | -₩3.9B | -₩1.1B | -₩2.1B | -₩4.1B | -₩743.3M |
| Pre-tax income | -₩1.6B | -₩1.2B | -₩2.2B | -₩4.5B | ₩788.9M |
| Net income | -₩2.2B | -₩1.1B | -₩2.2B | -₩4.5B | ₩896.5M |
| Total assets | ₩33.7B | ₩44.6B | ₩49.9B | ₩82.1B | ₩82.3B |
| Total liabilities | ₩8.3B | ₩9.8B | ₩17.3B | ₩43.3B | ₩42.5B |
| Total equity | ₩25.4B | ₩34.7B | ₩32.6B | ₩38.8B | ₩39.7B |
| Paid-in capital | ₩6.0B | ₩7.9B | ₩7.9B | ₩10.6B | ₩10.6B |
| Debt/equity (source value) | 32.5% | 28.3% | 53.2% | 111.6% | 107.1% |
Company outline (FSC)
- Market
- KOSPI
- Fiscal year end
- Dec
- Founded
- 2001-01-03
- Listed
- 01/01/29
- Employees
- 37
- Auditor
- 삼화회계법인
- Audit opinion
- 적정의견
- Corporate reg. no.
- 1101112141672
- Outline updated
- 2026-09-24
Check the original filings
Read the annual report and audit report before you decide anything. The link opens a DART search for this company's name.
Search DART for 진양화학Computed from the Financial Services Commission's company outline and summary statements (data.go.kr). Data as of 2026-09-24.